This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2024 Mar 28;143(13):1201-1202.

doi: 10.1182/blood.2023023443.

T-cell lymphoma: the CAR-T revolution is coming

Natalie S Grover¹, Anne W Beaven¹

Affiliations

PMID: 38546636
DOI: 10.1182/blood.2023023443

Free article

Editorial

T-cell lymphoma: the CAR-T revolution is coming

Natalie S Grover et al. Blood. 2024.

Free article

. 2024 Mar 28;143(13):1201-1202.

doi: 10.1182/blood.2023023443.

Authors

Natalie S Grover¹, Anne W Beaven¹

Affiliation

¹ The University of North Carolina at Chapel Hill.

PMID: 38546636
DOI: 10.1182/blood.2023023443

No abstract available

PubMed Disclaimer

Comment on

Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas.
Hill LC, Rouce RH, Wu MJ, Wang T, Ma R, Zhang H, Mehta B, Lapteva N, Mei Z, Smith TS, Yang L, Srinivasan M, Burkhardt PM, Ramos CA, Lulla P, Arredondo M, Grilley B, Heslop HE, Brenner MK, Mamonkin M. Hill LC, et al. Blood. 2024 Mar 28;143(13):1231-1241. doi: 10.1182/blood.2023022204. Blood. 2024. PMID: 38145560 Free PMC article.

References

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science